ArticleBMC women's health2026
Unraveling the fibrotic microenvironment in intrauterine adhesions through integrated metabolomics and proteomics.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIntrauterine adhesions (IUA) result from endometrial basal layer injury, leading to fibrous tissue formation and impaired fertility. Current treatments fail to fully reverse the fibrotic microenvironment. This study aimed to elucidate molecular mechanisms underlying IUA-associated fibrosis through integrated metabolomics and proteomics.
methodsFibrotic tissues from 35 moderate-to-severe IUA patients and normal endometrial samples from 20 controls were collected during hysteroscopy. Metabolomic profiling was performed using UPLC-MS, and proteomic analysis using label-free quantitative mass spectrometry. Differential metabolites (DEMs) and proteins (DEPs) were identified via OPLS-DA and statistical criteria (VIP > 1, P < 0.05 for DEMs; FDR-adjusted P < 0.05, FC ≥ 2 or ≤ 0.5 for DEPs). KEGG enrichment and integrated correlation analyses were conducted to explore pathway alterations and metabolite-protein interactions.
resultsA total of 565 DEMs were identified, primarily lipids, organic acids, and organooxygen compounds. KEGG enrichment revealed significant alterations in carbohydrate and amino acid metabolism pathways, with downregulation of TCA cycle intermediates and upregulation of glucose-6-phosphate, arginine, and methionine sulfoxide. Proteomics identified 2763 DEPs, with up-regulated proteins enriched in focal adhesion and ECM-receptor interaction pathways, and down-regulated proteins in DNA replication and complement cascades. Integrative analysis showed that carbohydrate and amino acid metabolism-related DEMs correlated negatively with fibrosis-related DEPs (e.g., collagens, TGF-β-related proteins), while focal adhesion-related DEPs correlated positively with fibrosis markers. Notably, fumarate showed strong negative correlations with COL18A1 (r=-0.71) and positive correlation with E-cadherin (r = 0.61).
conclusionsThis multi-omics study reveals that metabolic reprogramming, particularly involving glycolysis and amino acid metabolism, is closely associated with activation of the integrin-focal adhesion signaling pathway in IUA fibrosis. These findings provide new insights into potential therapeutic targets for endometrial repair and fertility preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.